NGAL kidney injury
Selected indexed studies
- Neutrophil gelatinase-associated lipocalin (NGAL) in kidney injury - A systematic review. (Clin Chim Acta, 2022) [PMID:36150522]
- Current concepts and advances in biomarkers of acute kidney injury. (Crit Rev Clin Lab Sci, 2021) [PMID:33556265]
- The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL). (Int J Mol Sci, 2023) [PMID:37445650]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Current concepts and advances in biomarkers of acute kidney injury. (2021) pubmed
- Therapeutic α-1-microglobulin ameliorates kidney ischemia-reperfusion injury. (2024) pubmed
- Neutrophil gelatinase-associated lipocalin (NGAL) in kidney injury - A systematic review. (2022) pubmed
- The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL). (2023) pubmed
- NGAL in the Development of Acute Kidney Injury in a Murine Model of Remote Ischaemic Preconditioning and Liver Ischaemia Reperfusion. (2024) pubmed
- Dapagliflozin ameliorates kidney injury following limb ischemia-reperfusion via the AMPK/SIRT1/NLRP3 pathway. (2025) pubmed
- CD4(+) T Cell-Derived NGAL Modifies the Outcome of Ischemic Acute Kidney Injury. (2020) pubmed
- Activating soluble guanylyl cyclase attenuates ischemic kidney damage. (2025) pubmed
- KIM-1, IL-18, and NGAL, in the Machine Learning Prediction of Kidney Injury among Children Undergoing Hematopoietic Stem Cell Transplantation-A Pilot Study. (2023) pubmed
- Treatment with MG53 ameliorates traumatic brain injury-associated acute kidney injury. (2025) pubmed